GDS directly promoted the development and progression of NASH by hepatic HTR2A, rather than HTR2B or HTR2C, those similar to hepatic steatosis was ameliorated with liver-specific Htr2a knockout and the deletion of GDS (Choi et al., 2018). This evidence concerns the gene HTR2A and Hepatic steatosis.